Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Essential oils may help hair health but lack strong scientific proof and can cause allergic reactions.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Tofacitinib is an effective and safe treatment for alopecia areata.

FFA patients have fewer melanocytes and thinner skin compared to others.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Nivolumab can cause hair loss as a rare side effect.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.